Patents by Inventor Jerry Roy Martin

Jerry Roy Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-N-acylfortimicin B derivatives and the chemical conversion of fortimicin B to fortimicin A
    Patent number: 4091032
    Abstract: This invention provides 4-N-acylfortimicin B derivatives of the structure ##STR1## wherein R is acyl, aminoacyl, N-monoloweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl, or substituted aminoacyl of the formula ##STR2## where R.sup.1 is an acyl radical derived from an amino acid or a short peptide, and the pharmaceutically acceptable salts thereof.The compounds are useful as intermediates for preparing 4-N-alkyl or substituted alkylfortimicin B derivatives. In addition to their utility as intermediates, some of the compounds of this invention are also useful as antimicrobial agents.
    Type: Grant
    Filed: September 23, 1976
    Date of Patent: May 23, 1978
    Assignee: Abbott Laboratories
    Inventors: John Soloman Tadanier, Jerry Roy Martin, Paul Kurath
  • 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
    Patent number: 4063014
    Abstract: A 4"-O-sulfonyl erythromycin derivative of the following structural formula: ##STR1## where R is selected from the group consisting of oxygen, oxime, and substituted oxime, R.sub.1 is hydrogen or hydroxy and R.sub.2 is selected from the group consisting of phthalimide, substituted amides, benzamides, substituted benzamides, sulfonamides, substituted sulfonamides, amines, substituted amines, phenylurea, substituted phenylurea, phenylthiourea, substituted phenylthiourea, thiophenol and substituted thiophenol, phenoxides and substituted phenoxides and R.sub.3 is hydrogen or methyl. The present sulfonyl derivatives of erythromycin A, B and C are useful as antibiotics.
    Type: Grant
    Filed: June 12, 1975
    Date of Patent: December 13, 1977
    Assignee: Abbott Laboratories
    Inventors: Robert Hallas, Jerry Roy Martin, John Soloman Tadanier
  • 6,6A-AND 6,7-Anhydroerythromycin B and derivatives thereof
    Patent number: 3963696
    Abstract: The present invention relates to the preparation of 6,6a-and 6,7-anhydroerythromycin B and derivatives thereof, which are useful as antibiotic.
    Type: Grant
    Filed: February 21, 1975
    Date of Patent: June 15, 1976
    Assignee: Abbott Laboratories
    Inventors: Jerry Roy Martin, John Soloman Tadanier, Alma Whitman Goldstein